Evidence map›Paper›PMID 38656030›Full record

ArticleArquivos brasileiros de oftalmologia2024

Transition from an in-person to a telemedicine diabetic retinopathy screening program.

Vanessa de O Almeida Barbieri, Luis Filipe Nakayama, Gabriel Almeida Barbieri, Suzane Eberhart Ribeiro da Silva, Daniel Cunha José Karmouche, Marcelle Naomi Oshiro Shinzato, Rodrigo Eiji Nakagawa, Caio Vinicius Regatieri, Fernando Korn Malerbi

Abstract read
In one paragraph

Article in Arquivos brasileiros de oftalmologia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Vanessa de O Almeida BarbieriRetina and Vitreous Sector, Hospital São Julião, Campo Grande, MS, Brazil.ORCID 0009-0007-6626-0015
Luis Filipe NakayamaDepartment of Ophthalmology, Universidade Federal de São Paulo, São Paulo, SP, Brazil.ORCID 0000-0002-6847-6748
Gabriel Almeida BarbieriUniversidade Federal de São Paulo, São Paulo, SP, Brazil.ORCID 0000-0002-1806-610X
Suzane Eberhart Ribeiro da SilvaRetina and Vitreous Sector, Hospital São Julião, Campo Grande, MS, Brazil.ORCID 0009-0007-5450-836X
Daniel Cunha José KarmoucheRetina and Vitreous Sector, Hospital São Julião, Campo Grande, MS, Brazil.ORCID 0000-0002-5225-8447
Marcelle Naomi Oshiro ShinzatoRetina and Vitreous Sector, Hospital São Julião, Campo Grande, MS, Brazil.ORCID 0009-0007-2499-6745
Rodrigo Eiji NakagawaRetina and Vitreous Sector, Hospital São Julião, Campo Grande, MS, Brazil.ORCID 0009-0009-2293-9370
Caio Vinicius RegatieriDepartment of Ophthalmology, Universidade Federal de São Paulo, São Paulo, SP, Brazil.ORCID 0000-0003-1511-8696
Fernando Korn MalerbiDepartment of Ophthalmology, Universidade Federal de São Paulo, São Paulo, SP, Brazil.ORCID 0000-0002-6523-5172

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTimely screening and treatment are essential for preventing diabetic retinopathy blindness. Improving screening workflows can reduce waiting times for specialist evaluation and thus enhance patient outcomes. This study assessed different screening approaches in a Brazilian public healthcare setting.

methodsThis retrospective study evaluated a telemedicine-based diabetic retinopathy screening implemented during the COVID-19 pandemic and compared it with in-person strategies. The evaluation was conducted from the perspective of a specialized referral center in an urban area of Central-West Brazil. In the telemedicine approach, a trained technician would capture retinal images by using a handheld camera. These images were sent to specialists for remote evaluation. Patient variables, including age, gender, duration of diabetes diagnosis, diabetes treatment, comorbidities, and waiting time, were analyzed and compared.

resultsIn total, 437 patients with diabetes mellitus were included in the study (mean age: 62.5 ± 11.0 years, female: 61.7%, mean diabetes duration: 15.3 ± 9.7 years, insulin users: 67.8%). In the in-person assessment group, the average waiting time between primary care referral and specialist evaluation was 292.3 ± 213.9 days, and the referral rate was 73.29%. In the telemedicine group, the average waiting time was 158.8 ± 192.4 days, and the referral rate was 29.38%. The telemedicine approach significantly reduced the waiting time (p<0.001) and significantly lowered the referral rate (p<0.001).

conclusionThe telemedicine approach significantly reduced the waiting time for specialist evaluation in a real-world setting. Employing portable retinal cameras may address the burden of diabetic retinopathy, especially in resource-limited settings.

Indexed as

COVID-19Diabetic RetinopathyTelemedicineAdultAgedBrazilFemaleHumansMaleMass ScreeningMiddle AgedPandemicsReferral and ConsultationRetrospective StudiesSARS-CoV-2Time Factors

Identifiers

PMID38656030
PMCPMC11622841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.